Terfenadin, Setirizin, Loratadin ve Akrivastinin kalp üzerine olan etkilerinin değerlendirilmesi
dc.citation.epage | 140 | en_US |
dc.citation.issueNumber | 3 | en_US |
dc.citation.spage | 139 | en_US |
dc.citation.volumeNumber | 31 | en_US |
dc.contributor.author | Erel, A. | en_US |
dc.contributor.author | Oztas, M. O. | en_US |
dc.contributor.author | Alkan, M. | en_US |
dc.contributor.author | Ilter, N. | en_US |
dc.contributor.author | Gurer, M. A. | en_US |
dc.date.accessioned | 2016-02-08T10:46:56Z | |
dc.date.available | 2016-02-08T10:46:56Z | |
dc.date.issued | 1997 | en_US |
dc.description.abstract | Design. - Non-sedative antihistanimic drugs, terfenadine, cetinizine, loratadine and acrivastine were given to four groups of patients each consisted of 10 patients for 10 days. Blood chemistry and daily electrocardrographic changes were followed. Conclusion. - Non-sedative antihistaminics have no cardiac side effects as they are given alone, in conventional treatment dose. | en_US |
dc.identifier.issn | 1308-6294 | |
dc.identifier.uri | http://hdl.handle.net/11693/25568 | |
dc.language.iso | Turkish | en_US |
dc.publisher | Galenos Yayinevi | en_US |
dc.source.title | Turkderm : Archives of the Turkish Dermatology and Venerology | en_US |
dc.subject | Acrivastine | en_US |
dc.subject | Cetirizine | en_US |
dc.subject | Heart | en_US |
dc.subject | Loratadine | en_US |
dc.subject | Terfenadine | en_US |
dc.title | Terfenadin, Setirizin, Loratadin ve Akrivastinin kalp üzerine olan etkilerinin değerlendirilmesi | en_US |
dc.title.alternative | Cardiovascular effects of terfenadine, cetirisine and laratodine | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- bilkent-research-paper.pdf
- Size:
- 68.58 KB
- Format:
- Adobe Portable Document Format